Krystle Vermes

Teflaro treats acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia (CABP).

Pediatric patients may now use ceftaroline fosamil (Teflaro) as a treatment for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia.

Relypsa is hoping to change its label for patiromer (Veltassa) for oral suspension in hyperkalemia treatment.

Fluciclovine F 18 is a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer.

Fluciclovine F 18 (Axumin) is a radioactive diagnostic agent that can be used to detect recurring prostate cancer.

The FDA has approved fluciclovine F 18 (Axumin), which is a radioactive diagnostic agent for injection that can be used to detect recurring prostate cancer.

Ajanta Pharma Limited has been given final approval from the FDA to launch zolmitriptan tablets, 2.5 mg and 5 mg, and voriconazole tablets, 50 mg and 200 mg.

Relypsa is hoping to change its label for patiromer (Veltassa) for oral suspension based on the results of 12 phase 1 drug-drug interaction studies.

Generic drug treats patients who have a high cholesterol and triglyceride in their blood.

Aurobindo Pharma Limited has received final approval from the FDA to launch fenofibrate tablets, 48 mg and 145 mg.

The FDA has approved Eisai's lenvatinib (Lenvima) for the treatment of advanced renal cell carcinoma in combination with everolimus after prior antiangiogenic therapy.

SOS Telecom Inc is voluntarily recalling dietary supplements that contain sildenafil.

Frovatriptan succinate tablets, the generic equivalent to Frova tablets, is administered for acute migraine headache treatment in adults.

Mylan has launched frovatriptan succinate tablets, 2.5 mg, which are the generic equivalent to Endo's Frova tablets.

Ameluz is used for photodynamic therapy treatment of mild to moderate actinic keratosis on the face and scalp.

The FDA has approved Biofrontera's topical prescription drug BF-200 ALA (Ameluz) and medical device BF-RhodoLED.

Ephedrine sulfate (Akovaz) is a drug administered parenterally to address hypotension in surgical settings.

The FDA has approved Flamel Technologies' new drug application for ephedrine sulfate (Akovaz), which is a drug administered parenterally to address hypotension in surgical settings.

FDA recommends health care facilities quarantine products from Medaus Inc that are intended to be sterile.

The FDA is warning health care professionals and patients about products intended to be sterile that were compounded by Medaus Inc.

Paul W. Franck allegedly manufactured and distributed products that violated the Federal Food, Drug, and Cosmetic Act.

The FDA has entered a permanent injunction against Paul W. Franck, who allegedly manufactured and distributed products that violated the Federal Food, Drug, and Cosmetic Act.

Crestor treats hypertriglyceridemia and homozygous familiar hypercholesterolemia, either alone or in combination with other cholesterol treatments.

The FDA has approved the first generic version of rosuvastatin calcium (Crestor) tablets.

Quest Diagnostics has received emergency use authorization from the FDA for the Zika Virus RNA Qualitative Real-Time RT-PCR test.

The FDA has approved Acadia Pharmaceuticals' pimavanserin (Nuplazid), the first drug that can help treat hallucinations and delusions associated with psychosis experienced by some patients with Parkinson's disease.

Fresenius Kabi USA is voluntarily recalling a single lot of bupivacaine HCI (Sensorcaine-MPF) injection due to the presence of glass particulate matter.

The FDA is reviewing the results of a Danish study that found the oral use of fluconazole (Diflucan) for yeast infections may increase the risk of miscarriage.

The FDA has approved Collegium Pharmaceutical Inc's oxycodone extended-release capsules (Xtampza ER) for severe pain.

Bevespi Aerosphere is a twice-daily, fixed-dose dual bronchodilator combining a long-acting muscarcinic antagonist and a long-acting beta-2 agonist.